Patent details

Basic Information

Publication number:

EP2237792

PCT Application Number:

US2008013998

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088655030

PCT Publication Number:

WO2009082485

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-C35 ANTIBODY COMBINATION THERAPIES AND METHODS

French Title of Invention:

THÉRAPIES DE COMBINAISON PAR ANTICORPS ANTI-C35 ET PROCÉDÉS

German Title of Invention:

ANTI-C35-ANTIKÖRPER-KOMBINATIONSTHERAPIEN UND VERFAHREN

SPC Number:

Dates

Filing date:

23/12/2008

Grant date:

24/05/2017

EP Publication Date:

13/10/2010

PCT Publication Date:

02/07/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/05/2017

EP B1 Publication Date:

24/05/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/12/2017

Expiration date:

23/12/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/05/2017

 

 

Name:

Vaccinex, Inc.

Address:

1895 Mt. Hope Avenue, Rochester, NY 14620, United States (US)

Inventor

1

Name:

EVANS, Elizabeth, E.

Address:

United States (US)

2

Name:

ZAUDERER, Maurice

Address:

United States (US)

Priority

Priority Number:

16763 P

Priority Date:

26/12/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/00; A61K 39/395; A61P 35/00; C07K 16/30; C07K 16/32;

Publication

European Patent Bulletin

Issue number:

201721

Publication date:

24/05/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/04/2018	Outgoing Correspondence	1